The hereditary spastic paraplegias.

Area of Science:

• Neurology
• Genetics

Background:

• Hereditary spastic paraplegias (HSPs) are a heterogeneous group of >90 genetic disorders characterized by progressive lower extremity spasticity and weakness.
• HSPs can be inherited via autosomal dominant, autosomal recessive, X-linked, or maternal (mitochondrial) patterns, presenting with varied clinical phenotypes.
• Early-onset forms may resemble spastic diplegic cerebral palsy, while later-onset forms typically progress insidiously.

Approach:

• Genetic testing is crucial for diagnosing many HSP subtypes.
• Gene discovery has identified diverse molecular pathways implicated in HSP pathogenesis.
• Pathological studies reveal axon degeneration in corticospinal tracts and dorsal column fibers in uncomplicated HSP.

Key Points:

• Molecular mechanisms underlying HSPs involve disruptions in axon transport, endoplasmic reticulum morphogenesis, vesicle transport, lipid metabolism, and mitochondrial function.
• Understanding these molecular processes is key to developing targeted therapies.
• Current treatment strategies focus on symptomatic relief, including spasticity management, bladder dysfunction, and comprehensive physical therapy.

Conclusions:

• Hereditary spastic paraplegias represent a complex group of genetic neurological disorders with diverse etiologies.
• Continued research into genetic and molecular underpinnings is essential for advancing therapeutic options.
• Multidisciplinary management, including physical therapy, is vital for improving the quality of life for affected individuals.